S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

eNavvi Integrates Amazon Pharmacy to Streamline Prescription Workflow

Doctors can now view real-time medication costs and stock availability directly within the eNavvi platform, thanks to a new partnership with Amazon Pharmacy. This integration aims to bypass traditional prescription hurdles by offering clinicians immediate delivery estimates and transparent pricing at the exact moment of care.

eNavvi Integrates Amazon Pharmacy to Streamline Prescription Workflow
Photo: Bio & News

The collaboration embeds Amazon Pharmacy’s logistical network into the eNavvi digital prescribing workflow. By comparing cash pricing against estimated insurance copays and applying manufacturer discounts automatically, the system removes the uncertainty of drug availability and unexpected pharmacy costs. This is particularly relevant for addressing access challenges in pharmacy deserts, where consistent medication supply remains a persistent barrier.

Amazon Pharmacy currently offers same-day delivery in nearly 3,000 U.S. cities, with plans to reach 4,500 locations by the end of 2026. Beyond basic delivery, Prime members gain access to deeper savings on generics, while the RxPass subscription service allows patients to manage chronic conditions for a flat $5 monthly fee. According to eNavvi CEO Simon Chang, the primary goal is to minimize friction, ensuring that physicians spend less time managing prescription logistics and more time focused on patient health outcomes.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!